Home » Topics » BioWorld Science

BioWorld Science
RSS

Gilead and insitro enter strategic collaboration to discover and develop new therapies for NASH

April 17, 2019

Wave Life Sciences presents phase I data and updates on development of suvodirsen

April 17, 2019

IL-7 receptor plays role in severe IBD

April 17, 2019

New candidate drug for visceral leishmaniasis

April 17, 2019

Preventing drug tolerance to forestall resistance

April 17, 2019

Cortexyme launches phase II/III study of COR-388 in subjects with Alzheimer's disease

April 16, 2019

Interim results presented from phase II study of chikungunya virus vaccine candidate

April 16, 2019

Positive 12-month data presented from phase II study of Clascoterone

April 16, 2019

Positive interim results presented from phase I study of CERC-301

April 16, 2019

CStone Pharmaceuticals announces dosing of first patient in phase III GEMSTONE-303 study

April 16, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026